Press kit

Everything you need to tell the story.

Podcast hosts, journalists, and analysts: this is the one-stop kit. If something's missing, email press@habitcure.com and we'll ship it same day.

One-line pitch

HabitCure reads the biosignals your body sends every day and turns them into the answers you needed before the moment arrived.

100-word bio

HabitCure Inc. is a digital health company building continuous biosignal coaching for consumers, athletes, clinicians, and military units. 6+ patent-pending detection methods — Cardiac Drift, glucose morphology, LSI, paired-window athletic, and pathway conflict — run inside a single unified inference engine across four editions of the app. Founded by Rick Duchin (CEO) with Eric Jay Duchin as the inventor of record, HabitCure is in closed TestFlight beta with public launch planned for late 2026. The company is based in San Jose, California.

Assets

Key facts

• Founded: 2025 (as HabitCure Inc.)
• Headquarters: San Jose, California
• Founder & CEO: Rick Duchin
• Inventor of record: Eric Jay Duchin
• Product: iOS app, four editions (Consumer, Elite, Professional, Military)
• Patents pending: Five USPTO provisional filings (May 2026)
• Current stage: Closed TestFlight beta
• Public launch: Late 2026

Interview topics Rick can go deep on

• What Cardiac Drift is and why every wearable misses it
• Building a real-time biosignal engine on-device
• The paired-window framework — why interventions must be measured against paired baselines
• Why "the pattern is the product" and how HabitCure disagrees with the entire wearable industry
• Filing five provisional patents as a solo founder
• iOS development for HIPAA-adjacent health apps
• Building for four segments — consumer, elite athlete, clinician, military — with one engine